{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:27:33Z","timestamp":1759937253158,"version":"3.41.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005863","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T23:23:45Z","timestamp":1484177025000},"page":"e5863","source":"Crossref","is-referenced-by-count":6,"title":["Febuxostat-induced agranulocytosis in an end-stage renal disease patient"],"prefix":"10.1097","volume":"96","author":[{"given":"Xue Er","family":"Poh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Te","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Nan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-36-20210309","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"10","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken"},{"key":"R2-36-20210309","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"10","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R3-36-20210309","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"8","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-36-20210309","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"23","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-36-20210309","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"9","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"R7-36-20210309","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0268-960X(90)90002-A","article-title":"Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors","volume":"4","author":"Pisciotta","year":"1990","journal-title":"Blood Rev"},{"key":"R8-36-20210309","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"4","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R9-36-20210309","first-page":"106","article-title":"Febrile neutropenia in patients with acute leukemia following chemotherapy: a retrospective review","volume":"17","author":"Pei","year":"2006","journal-title":"J Intern Med Taiwan"},{"key":"R10-36-20210309","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-0609.1985.tb02813.x","article-title":"Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis","volume":"5","author":"Heit","year":"1985","journal-title":"Scand J Haematol"},{"key":"R11-36-20210309","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"2","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R12-36-20210309","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40265-015-0360-7","article-title":"Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout","volume":"4","author":"Frampton","year":"2015","journal-title":"Drugs"},{"key":"R14-36-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10157-012-0763-7","article-title":"Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment","volume":"1","author":"Horikoshi","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R15-36-20210309","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jcpt.12057","article-title":"Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease","volume":"3","author":"Kobayashi","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"R16-36-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hdi.12313","article-title":"Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: a randomized controlled study","volume":"4","author":"Tsuruta","year":"2015","journal-title":"Hemodial Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T09:57:11Z","timestamp":1749895031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701130-00036"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005863","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}